Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study.
Saved in:
| Title: | Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study. |
|---|---|
| Authors: | Sivakumaran, T.1 (AUTHOR) tharani.sivakumaran@petermac.org, Mileshkin, L.1,2 (AUTHOR), Grant, P.3 (AUTHOR), Na, L.1 (AUTHOR), DeFazio, A.4,5 (AUTHOR), Friedlander, M.6 (AUTHOR), Obermair, A.7 (AUTHOR), Webb, P.M.8 (AUTHOR), Au-Yeung, G.1,2 (AUTHOR) |
| Source: | Gynecologic Oncology. Jul2020, Vol. 158 Issue 1, p47-53. 7p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 143879281 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Sivakumaran%2C+T%2E%22">Sivakumaran, T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> tharani.sivakumaran@petermac.org</i><br /><searchLink fieldCode="AR" term="%22Mileshkin%2C+L%2E%22">Mileshkin, L.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grant%2C+P%2E%22">Grant, P.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Na%2C+L%2E%22">Na, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22DeFazio%2C+A%2E%22">DeFazio, A.</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Friedlander%2C+M%2E%22">Friedlander, M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Obermair%2C+A%2E%22">Obermair, A.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Webb%2C+P%2EM%2E%22">Webb, P.M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Au-Yeung%2C+G%2E%22">Au-Yeung, G.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Gynecologic+Oncology%22">Gynecologic Oncology</searchLink>. Jul2020, Vol. 158 Issue 1, p47-53. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=143879281 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ygyno.2020.04.706 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 47 Titles: – TitleFull: Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sivakumaran, T. – PersonEntity: Name: NameFull: Mileshkin, L. – PersonEntity: Name: NameFull: Grant, P. – PersonEntity: Name: NameFull: Na, L. – PersonEntity: Name: NameFull: DeFazio, A. – PersonEntity: Name: NameFull: Friedlander, M. – PersonEntity: Name: NameFull: Obermair, A. – PersonEntity: Name: NameFull: Webb, P.M. – PersonEntity: Name: NameFull: Au-Yeung, G. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 00908258 Numbering: – Type: volume Value: 158 – Type: issue Value: 1 Titles: – TitleFull: Gynecologic Oncology Type: main |
| ResultId | 1 |
